News & Events

Caris Life Sciences Announces Launch of National Cancer Research Observational Registry
Feb 16, 2010

The Caris Registry’s Molecular Data To Help Predict Responses To Cancer Therapy

IRVING, Texas– February 16, 2010 – Caris Life Sciences (Caris®) – a leading provider of integrated anatomic pathology and oncology testing services, including molecular profiling and hematopathology – today announced the launch of The Caris Registry℠, a biomarker-driven repository to help predict clinical benefit and patients’ responses to cancer therapy including chemotherapy, immunotherapy and biological therapy.   

“The Caris Registry provides a centralized, real-time data repository through which treating physicians can share and expand their understanding of personalized treatment options for their patients,” said Alan Wright, Senior Vice President of Strategy at Caris. “...

read more

Caris Diagnostics Announces Name Change of Parent Company to Caris Life Sciences, Inc.
Jan 19, 2010

IRVING, Texas; January 19th, 2010 – Caris Diagnostics (Caris Dx) today announced that its parent company’s name will change to Caris Life Sciences, Inc., effective immediately. The new name reflects the Company’s successful evolution into a multi-faceted organization that is pioneering precision healthcare, leading to improved patient outcomes and lowered healthcare costs. Caris Life Sciences is focused on five key areas of personalized medicine: Anatomic Pathology, Molecular Profiling, Proprietary Blood-Based Diagnostics, Pharmaceutical Services, and Research and Development.

“The promise of precision healthcare is quickly becoming a reality, thanks in large part to the revolutionary advances in molecular science. Caris Life Sciences reflects our mission of providing quality...

read more

Caris Diagnostics Names New Vice Chairman and Board Member, Dr. Jonathan Knowles

Dec 16, 2009

IRVING, Texas, and PHOENIX, Arizona; December 16th, 2009 – Caris Diagnostics™ – a leading provider of integrated anatomic pathology and oncology testing services, including molecular profiling and hematopathology, announced that Professor Jonathan Knowles, PhD, has joined its Board of Directors as of September 1, 2009 and accepted the position of Vice Chairman starting on January 1, 2010. In these capacities, Dr. Knowles will provide scientific and strategic guidance, will support the identification and expansion of R&D opportunities, and will assist with the development of Caris’ international presence.

Dr. Knowles’ appointments to these positions continues a distinguished career that has spanned decades in both academia and the pharmaceutical industry, including most...

read more

Dr. George Poste, Caris Diagnostics Vice Chairman and Chief Scientific Advisor, Receives the 2009 Scrip Lifetime Achievement Award
Dec 14, 2009

IRVING, Texas, and PHOENIX, Arizona; December 14, 2009 – Caris Diagnostics™ is pleased to announce Vice-Chairman and Chief Scientific Advisor George Poste, D.V.M., Ph.D, D.Sc., F.R.S., was named the 2009 recipient of the prestigious Scrip Lifetime Achievement Award. Dr. Poste accepted the honor during the 5th Annual Scrip Awards ceremony in London on November 18th, hosted by Scrip World Pharmaceutical News.

The internationally-renowned Scrip Awards acknowledge outstanding achievements in the pharmaceutical, biotech and allied industries. An esteemed panel of judges comprised of independent industry experts from around the world selected Dr. Poste for his nearly four decades of research accomplishments spanning academia, industry, and government.

“I am deeply honored to...

read more

Caris Diagnostics Names Jerry Martino Senior Vice President, Chief Financial Officer
Oct 29, 2009

IRVING, Texas and PHOENIX, Arizona; October 19, 2009 – Caris Diagnostics™ – a leading provider of integrated anatomic pathology and oncology testing services, including molecular profiling and hematopathology – today announced the appointment of Jerry Martino as Senior Vice President, Chief Financial Officer. Mr. Martino will provide executive leadership for the customary financial functions of the company, as well as strategic guidance for integrated corporate functions that serve all business groups. Additionally, Mr. Martino will help to shape the international strategy for the company.

Jerry brings extensive international and domestic business leadership experience to Caris. Most recently, he was the Executive Vice President and Chief Operating Officer for Par Pharmaceutical...

read more

Caris Diagnostics Enhances its Medical Staff with the Addition of 22 Subspecialty Pathologists
Oct 07, 2009

IRVING, Texas; October 07, 2009– Caris Diagnostics™ (a division Caris Life Sciences™), a leading provider of integrated anatomic pathology and molecular testing services, today announced that it has hired 22 subspecialist pathologists in the areas of Dermatopathology, GI pathology, Hematopathology, Oncologic pathology/tumor profiling, and Urologic pathology, bringing the total number of Caris Diagnostics’ expert pathologists to 61.

“We are indeed honored to have such distinguished academic leaders choose to join our team,” commented Richard H. Lash, M.D., Chief Medical Officer of Caris Diagnostics. “Their contribution to our ongoing diagnostic, educational, and research activities will ensure that Caris Diagnostics secures its position as the premier diagnostics company.”

...
read more